MANKIND PHARMA
Sector : Pharmaceuticals and health care | Largecap | BSE
Here's the live share price of Mankind Pharma along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.83₹ 21.85
As on Sep 19, 2025, 4:01 PM IST
Mankind Pharma Price Performance
Today's LowToday's High
₹2,626.20₹2,670.00
₹2,660.00
52 Weeks' Low52 Weeks' High
₹2,115.50₹3,050.00
₹2,660.00
Open Price
₹2,647.60
Prev. Close
₹2,638.15
Volume
12,185
Over the last 5 years, the share price of Mankind Pharma has gained 13.31% CAGR. Over the past year, the corresponding return has been 9.42%.
Mankind Pharma’s current P/E of 58.01x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
Mankind Pharma Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Mankind Pharma | 3.11 | 6.77 | 14.52 | 23.06 | 9.42 | 23.16 | 13.31 |
| Sun Pharmaceutical Industries | 2.46 | 1.83 | 0.53 | -4.47 | -10.31 | 23.72 | 26.88 |
| Divi's Laboratories | 2.72 | 1.77 | -4.66 | 6.42 | 13.89 | 19.59 | 14.40 |
| Cipla | 0.10 | 1.71 | 6.22 | 5.14 | -3.85 | 15.04 | 15.46 |
| Torrent Pharmaceuticals | 2.14 | -0.21 | 14.98 | 14.09 | 8.71 | 35.04 | 21.92 |
| Dr. Reddy's Laboratories | 0.55 | 6.29 | -0.21 | 12.94 | 1.71 | 17.31 | 5.19 |
| Zydus Lifesciences | -0.75 | 4.85 | 9.18 | 14.01 | -1.65 | 42.32 | 21.23 |
| Lupin | 0.75 | 4.56 | 6.49 | -0.13 | -5.17 | 47.48 | 14.61 |
| Alkem Laboratories | 2.04 | 3.13 | 16.34 | 14.54 | -9.45 | 19.64 | 14.17 |
| Aurobindo Pharma | 2.17 | 2.57 | 3.24 | -3.89 | -26.78 | 29.10 | 7.17 |
| Abbott India | -1.82 | -8.05 | -1.97 | 0.22 | 8.72 | 20.47 | 13.85 |
| Glenmark Pharmaceuticals | -2.16 | 7.13 | 27.12 | 40.23 | 26.25 | 77.84 | 34.53 |
| Laurus Labs | 4.19 | 5.51 | 44.52 | 54.04 | 98.51 | 22.52 | 26.75 |
| Biocon | 1.26 | 1.57 | 6.05 | 8.19 | 2.48 | 8.42 | -2.92 |
| Anthem Biosciences | 1.98 | 3.87 | 16.36 | 16.36 | 16.36 | 5.18 | 3.08 |
| GlaxoSmithKline Pharmaceuticals | -1.38 | -2.86 | -14.32 | -3.47 | 1.40 | 24.71 | 10.06 |
| Ipca Laboratories | 6.86 | 1.39 | 3.24 | 3.63 | -3.35 | 17.89 | 6.17 |
| Cohance Lifesciences | -7.40 | -1.19 | -8.09 | -21.72 | -22.85 | 25.51 | 19.13 |
| Gland Pharma | 0.04 | 3.93 | 18.34 | 27.73 | 11.67 | -3.43 | 2.12 |
| Ajanta Pharma | -1.07 | -5.76 | 0.27 | -2.77 | -20.40 | 26.20 | 19.22 |
Over the last one year, Mankind Pharma has gained 9.42% compared to peers like Sun Pharmaceutical Industries (-10.31%), Divi's Laboratories (13.89%), Cipla (-3.85%). From a 5 year perspective, Mankind Pharma has underperformed peers relative to Sun Pharmaceutical Industries (26.88%) and Divi's Laboratories (14.40%).
Mankind Pharma Financials
Mankind Pharma Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 2,579.58 | 2,596.46 |
| 10 | 2,579.24 | 2,583.79 |
| 20 | 2,556.51 | 2,566.9 |
| 50 | 2,559.12 | 2,537.25 |
| 100 | 2,486.89 | 2,509.64 |
| 200 | 2,506.9 | 2,474.86 |
Mankind Pharma Share Holding Pattern
In the latest quarter, Mankind Pharma saw a drop in promoter holding to 72.67%, while DII stake increased to 11.50%, FII holding rose to 13.07%, and public shareholding moved down to 2.75% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Mankind Pharma Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| SBI Blue Chip Fund | 40,72,930 | 1.92 | 1,006.58 |
| HDFC Top 100 Fund - Regular Plan | 18,38,223 | 1.21 | 454.3 |
| Axis ELSS Tax Saver Fund | 13,30,911 | 0.95 | 328.92 |
| SBI Contra Fund | 13,28,039 | 0.7 | 328.21 |
| Invesco India Contra Fund | 11,03,081 | 1.44 | 272.62 |
| Axis Flexi Cap Fund | 10,76,417 | 2.08 | 266.03 |
| Axis Focused Fund | 10,37,596 | 2.09 | 256.43 |
| PGIM India Midcap Opportunities Fund | 9,23,014 | 2 | 228.11 |
| Canara Robeco Bluechip Equity Fund | 9,14,097 | 1.39 | 225.91 |
| ICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund | 8,73,005 | 3.5 | 215.75 |
Mankind Pharma Futures
| Price | (%) As on Invalid Date IST |
| Open Interest | (%) |
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) |
Mankind Pharma Options
Mankind Pharma Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 15, 2025, 10:32 PM IST | Mankind Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 11, 2025, 4:03 AM IST | Mankind Pharma - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 20 |
| Sep 09, 2025, 5:57 AM IST | Mankind Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Sep 02, 2025, 11:39 PM IST | Mankind Pharma - Intimation Of Receipt Of Approval For Reclassification |
| Aug 27, 2025, 9:08 PM IST | Mankind Pharma - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
About Mankind Pharma
Mankind Pharma Ltd. is a Public Limited Listed company incorporated on 03/07/1991 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1991PLC044843 and registration number is 044843. Currently Company is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company's Total Operating Revenue is Rs. 9497.80 Cr. and Equity Capital is Rs. 41.26 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address208, Okhla Industrial Estate, Phase-III, New Delhi Delhi 110020
- Contact
Management
- Mr. Ramesh JunejaChairman & Wholetime Director
- Mr. Rajeev JunejaVice Chairman & Mng.Director
- Ms. Sheetal AroraWhole Time Director
- Mr. Satish Kumar SharmaWhole Time Director
- Mr. Vivek KalraIndependent Director
- Mr. Tilokchand Punamchand OstwalIndependent Director
- Mr. Bharat AnandIndependent Director
- Ms. Vijaya SampathIndependent Director
FAQs on Mankind Pharma Share Price
What is the share price of Mankind Pharma?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Mankind Pharma is ₹2,660.00 as on Sep 19, 2025.
What kind of stock is Mankind Pharma?
The Mankind Pharma is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
What is the Market Cap of Mankind Pharma?
The market cap of Mankind Pharma is ₹109,793.76 Cr as on Sep 19, 2025.
What are today's High and Low prices of Mankind Pharma?
Today’s highest and lowest price of Mankind Pharma are ₹2,670.00 and ₹2,626.20.
What are the 52 Week High and 52 Week Low of Mankind Pharma?
The 52-week high/low is the highest and lowest price at which Mankind Pharma stock has traded in the past 52-week or nearly a year. The 52-week high of Mankind Pharma is ₹3,050.00 and 52-week low of Mankind Pharma is ₹2,115.50 as on Sep 19, 2025.
How has the Mankind Pharma performed historically in terms of returns?
The Mankind Pharma has shown returns of 0.83% over the past day, 6.77% for the past month, 14.52% over 3 months, 9.42% over 1 year, 23.16% across 3 years, and 13.31% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Mankind Pharma?
P/E ratio of and PB ratio of Mankind Pharma are 58.01 and 10.39 on Sep 19, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data